Ocuphire Pharma, Inc. Registration of securities issued in business combination transactions

Registration of securities issued in business combination transactions

Leases (Tables)

Leases (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2020

Dec. 31, 2019

Leases [Abstract]

Summary Of Right Of Use Lease Assets And Lease Liabilities


Right-of-Use Assets		$	203,348

Operating Lease Liabilities
Current		$	139,765
Long Term			63,605
Total Operating Lease Liabilities		$	203,370

Components Of Lease Expense


	For the Three Months Ended June 30,				For the Six Months Ended June 30,
	2020		2019		2020		2019
Operating lease cost	$	36,770	$	47,129	$	73,541	$	127,407
Variable lease cost		6,110		6,659		11,803		22,672

Total Lease Cost	$	42,880	$	53,788	$	85,344	$	150,079

Scheduled Future Minimum Lease Payments


Year Ending December 31:
2020 (excluding the six months ended June 30, 2020)	$	78,437
2021		65,364
Minimum lease payments		143,801
Less: Imputed interest		(7,604)
Present value of minimum lease payments	$	136,197


Year Ending December 31:
2020	$	155,280
2021		65,364
Minimum lease payments		220,644
Less: Imputed interest		(17,274)
Present value of minimum lease payments		203,370
Less: current maturities of lease obligations		(139,765)
Long-term lease obligations	$	63,605